Legal status · United States
Is Setmelanotide legal in the United States?
Yes. Setmelanotide is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Setmelanotide in the United States at a glance
| Classification | FDA-approved, prescription only |
|---|---|
| FDA approval status | FDA-approved (Imcivree) for specific genetic obesity indications |
| Evidence level | Strong (research strength: Strong) |
| Reviewed | Sep 2026 |
Classification and note come from the Setmelanotide profile, checked against U.S. Food and Drug Administration (FDA) listings at the reviewed date.
What this means
- 01
FDA has approved Setmelanotide for at least one labeled indication, so a pharmaceutical-grade product exists in the United States and is dispensed on prescription.
- 02
Approval is indication-specific. Uses outside the label are a clinical decision for a prescriber, not something the approval itself authorizes.
- 03
Unlicensed online vials, including those labeled "research use only", are not the approved product and are not covered by the approval.
What Setmelanotide is
An FDA-approved MC4R agonist for rare genetic forms of obesity driven by defects in the melanocortin pathway.
Setmelanotide is a selective MC4R agonist approved as Imcivree for obesity caused by specific rare genetic deficiencies (POMC, PCSK1, and LEPR) and for Bardet-Biedl syndrome. It restores signaling in a pathway central to appetite regulation and produces meaningful weight loss in these targeted populations.
Mechanism: Selectively agonizes the melanocortin-4 receptor (MC4R) to restore satiety signaling disrupted by upstream genetic defects.
Regulatory history: FDA-approved (Imcivree) for specific genetic obesity indications
How FDA treats this kind of product
Approves prescription drugs by indication and polices unapproved products, including peptides sold online. Compounding pharmacies may prepare some compounds under a prescription when the FDA places them on a permitted bulk-substances category.
The classification above is the The Longevity Archive reading of U.S. Food and Drug Administration listings for Setmelanotide at the reviewed date, not a legal opinion. Rules change, and importing, prescribing and possessing a compound can each be treated differently. Check the regulator directly before acting on anything here.
Setmelanotide in other countries
United Kingdom
Approved medicineLicensed, prescription only (MHRA)
Is Setmelanotide legal in the United Kingdom?Australia
Approved medicineTGA-registered, prescription only
Is Setmelanotide legal in Australia?Canada
Approved medicineHealth Canada approved, prescription only
Is Setmelanotide legal in Canada?Frequently asked questions
Is Setmelanotide legal in the United States?
Yes. Setmelanotide is an approved medicine in the United States, classified as "FDA-approved, prescription only". Approval covers its labeled indication and it is supplied on prescription, not over the counter. Products labeled "research use only" fall outside that approval and the label does not make human use lawful. Human evidence: Strong.
Can I buy Setmelanotide in the United States?
Only with a prescription. Setmelanotide is classified as "FDA-approved, prescription only" in the United States, so it is dispensed by pharmacies against a prescription for its approved indication. Buying it from unlicensed online sellers or as a "research chemical" is outside that system and carries no regulatory protection.
Is Setmelanotide FDA approved?
Yes. FDA status: FDA-approved (Imcivree) for specific genetic obesity indications. Current US classification: "FDA-approved, prescription only". Evidence level: Strong.
Related compounds in the United States
Full research profile
Mechanism, cited studies, FDA status and the full legal summary for Setmelanotide live on its compound profile.
Setmelanotide profileThis page is general information about the regulatory status of Setmelanotide in the United States, current as of Sep 2026. It is not legal advice, and classifications change; check U.S. Food and Drug Administration directly or consult a lawyer for a specific situation. Educational use only. This database summarizes published research. It is not medical advice and contains no dosing protocols or recommendations for personal use. The Longevity Archive has no vendor relationships and does not recommend where to buy anything.